Your Health Magazine Contributor More Health News & Research Articles Retatrutide in Australia: Benefits, Weight Management Potential, and What To Know Retatrutide in Australia has become a growing topic of interest as more people search for clear, science-based information about next-generation weight management compounds
Key results at 80 weeks: Participants on the 4 mg dose lost an average of 47.2 lbs (19.0%) Participants on the 12 mg dose lost an average of 70.3 lbs (28.3%) 45.3% of participants on the 12 mg dose achieved at least 30% weight loss a level historically associated with bariatric surgery outcomes The 4 mg dose showed a lower rate of discontinuation due to adverse events than even placebo In a study extension to 104 weeks, participants with a starting BMI of 35 or higher who received 12 mg lost up to an average of 85.0 lbs (30.3%)
FDA clarifies policies for compounders as national GLP-1 supply beings to stabilize
Kuwata H, Yabe D, Murotani K, Fujiwara Y, Haraguchi T, Kubota S, et al
Step 1: Initial assessment Complete a short online questionnaire covering your health history, BMI, and prior GLP-1 use
